2025-05-12 - Analysis Report
Okay, here's an analysis of Natera Inc. (NTRA), incorporating the data you provided.

## Natera Inc. (NTRA) Analysis

**0. Overview**

This report analyzes Natera Inc. (NTRA), comparing its performance to the S&P 500 (VOO), examining recent price movements, technical indicators, news events, and financial data to provide a comprehensive overview.

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** NTRA
*   **Company Description:** Natera Inc. is a diagnostics company specializing in cell-free DNA testing.
*   **NTRA Cumulative Return:** 145.60%
*   **VOO Cumulative Return:** 82.29%
*   **Absolute Spread (NTRA - VOO):** 63.3%
*   **Relative Spread:** 16.7% (Indicates NTRA's performance is in the 16.7th percentile of its historical spread relative to VOO)

**Alpha, Beta Analysis Table**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
|------------|---------|-------|----------|--------|--------|
| 2015-2017  | -6.0%   | 62.4% | -34.0%   | -0.1   | 1.1    |
| 2016-2018  | 29.0%   | 80.1% | 11.0%    | 0.0    | 1.8    |
| 2017-2019  | 159.0%  | 80.1% | 128.0%   | 1.3    | 4.3    |
| 2018-2020  | 530.0%  | 80.1% | 501.0%   | 0.7    | 12.7   |
| 2019-2021  | 355.0%  | 62.9% | 298.0%   | 0.3    | 11.9   |
| 2020-2022  | -119.0% | 62.9% | -127.0%  | 0.3    | 5.1    |
| 2021-2023  | -482.0% | 69.9% | -501.0%  | 1.3    | 8.0    |
| 2022-2024  | -75.0%  | 70.6% | -94.0%   | 1.3    | 20.2   |
| 2023-2025  | 94.0%   | 72.8% | 69.0%    | 0.9    | 20.8   |

*   **Analysis:**
    *   NTRA has significantly outperformed the S&P 500, but with substantial volatility.
    *   The Alpha/Beta analysis shows periods of high alpha (outperformance) and beta values that fluctuate, reflecting changes in the stock's sensitivity to market movements. In recent periods, Beta has generally been high (1.3)
    *   High MDD(Maximum Drawdown) values indicate significant risk.
    *   CAGR varies greatly from year to year (from -482% to 530%)
    *   **Interpretation:** NTRA has the *potential* to significantly outperform the market, but it comes with a high level of risk. The inconsistency of alpha and beta suggests that NTRA's returns are not consistently tied to market movements, and may depend on company-specific events.

**2. Recent Price Movements**

*   **Current Price:** 162.57
*   **Last Market Data:** Price: 151.95, Previous Close: 162.57, Change: -6.53
*   **5-Day Moving Average:** 158.44
*   **20-Day Moving Average:** 151.79
*   **60-Day Moving Average:** 150.88
*   **Analysis:**
    *   The price closed significantly lower than the previous close (-6.53) and well below current price (162.57), this suggests negative market sentiment and selling pressure.
    *   The 5-day moving average is above the 20-day and 60-day moving averages, suggesting short-term upward momentum *before* the last trading day's decline.
    *   The 20-day moving average is slightly above the 60-day moving average, indicating a possible continuation of the short-term trend.
    *   **Interpretation:** While longer-term trends might be slightly positive, recent data indicates a pullback. Investors should watch for confirmation of a continued downtrend or a potential rebound.

**3. Technical Indicators**

*   **Market Risk Indicator (MRI):** 0.3707 (Low Risk)
*   **RSI:** 67.74 (Approaching Overbought)
*   **PPO:** 0.85
*   **Recent (20-day) Relative Spread Change:** 2.2 (Short-term Increase)
*   **Expected Return:** 83.1% (vs. S&P 500, long-term)
*   **Analysis:**
    *   **MRI:** Indicates low market risk.
    *   **RSI:**  Indicates that the stock is approaching overbought territory, suggesting a potential pullback or consolidation.
    *   **PPO:** Positive value, indicating a bullish trend, though not extremely strong.
    *   **Relative Spread Change:** A 2.2 increase suggests recent outperformance of NTRA versus VOO.
    *   **Recent Price Change:** Significant change in the last market day (-6.53 from 162.57 to 151.95). This suggests a potential reversal of the recent short-term upward trend indicated by the relative spread change. This needs careful monitoring.
    *   **Expected Return:** The high expected return suggests that analysts believe NTRA has strong growth potential over the long term.
    *   **Interpretation:** The technical indicators present a mixed picture. While the low MRI and positive PPO are bullish, the high RSI and recent price drop indicates the possibility of a short-term correction.

**4. Recent News & Significant Events**

*   **[2025-05-10]:** Major business developments, regulatory changes, or market events.
*   **[2025-05-08]:** Analyst discussion of recent performance and outlook.
*   **[2025-05-09]:** Notable stock volatility.
*   **[2025-05-12]:** Highlighted risks and opportunities, advice to monitor news.
*   **Analysis:**
    *   The news suggests that NTRA is experiencing significant activity, including business developments, regulatory scrutiny, and market volatility.
    *   **Interpretation:** Investors should closely monitor news and company announcements to understand the drivers behind the stock's recent movements.

**5. Recent Earnings Analysis**

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2025-05-09 | -0.50  | 0.50 B$     |
| 2024-11-12 | -0.26  | 0.44 B$     |
| 2024-08-09 | -0.30  | 0.41 B$     |
| 2024-05-10 | -0.56  | 0.37 B$     |
| 2025-05-09 | -0.56  | 0.37 B$     |

*   **Analysis:**
    *   NTRA is currently unprofitable, as indicated by the negative EPS values.
    *   Revenue has generally been increasing over the reported quarters, but may have plateaued/decreased in the most recent reading.
    *   **Interpretation:** While revenue growth is positive, the lack of profitability is a concern. Investors should monitor the company's progress towards profitability. The recent drop in revenue from 0.50B to 0.37B is concerning and needs further investigation. This may be an input error and clarification is required.

**6. Financial Information**

| Quarter    | Revenue | Profit Margin | Equity  | ROE      |
|------------|---------|---------------|---------|----------|
| 2024-12-31 | $0.48B  | 62.94%        | $1.20B  | -4.50%   |
| 2024-09-30 | $0.44B  | 61.79%        | $0.88B  | -3.60%   |
| 2024-06-30 | $0.41B  | 58.83%        | $0.84B  | -4.48%   |
| 2024-03-31 | $0.37B  | 56.72%        | $0.79B  | -8.51%   |
| 2023-12-31 | $0.31B  | 51.38%        | $0.77B  | -10.20%  |

*   **Analysis:**
    *   Revenue has shown consistent growth over the past five quarters.
    *   Profit margins are high and have been increasing, indicating improved operational efficiency.
    *   Equity has increased significantly, suggesting successful capital raising or asset growth.
    *   ROE (Return on Equity) is negative, reflecting the company's current lack of profitability, despite the increase in equity and high profit margins.
    *   **Interpretation:** The increasing revenue, high profit margins, and rising equity are positive signs. However, the negative ROE underscores the need for NTRA to achieve profitability.

**7. Overall Assessment**

Natera Inc. (NTRA) presents a mixed investment picture. The company has shown significant growth potential, as evidenced by its strong historical outperformance compared to the S&P 500 and high expected returns.  Revenue growth, high profit margins, and increasing equity are positive indicators. However, NTRA carries substantial risk due to its high volatility, negative profitability (EPS and ROE), and exposure to regulatory and market-related uncertainties as highlighted in recent news. The significant price drop on the last trading day should also be cause for concern.

**Recommendation:**

A cautious approach is warranted. Investors should:

*   **Monitor News and Company Announcements:** Stay informed about business developments, regulatory changes, and market events.
*   **Assess Profitability:**  Track NTRA's progress towards achieving profitability.
*   **Manage Risk:**  Be aware of the high volatility and potential for significant drawdowns.
*   **Consider a Small Allocation:**  Due to the risk profile, a small allocation within a diversified portfolio may be appropriate for investors with a high-risk tolerance and a long-term investment horizon.
*   **Investigate Discrepancies:** The two different revenue readings for 2025-05-09 (0.50B and 0.37B) need clarification.

This analysis is based on the provided data and should not be considered financial advice. Investors should conduct their own due diligence before making any investment decisions.
